- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PharmaEssentia (6446)
PharmaEssentia stock price live, this page displays TW 6446 stock exchange data. View the 6446 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PharmaEssentia real time stock price chart below.
What Is the PharmaEssentia Stock Price Today?
The PharmaEssentia stock price today is 1,195.00.
What Is the Stock Symbol for PharmaEssentia?
The stock symbol for PharmaEssentia is "6446."
What Stock Exchange Does PharmaEssentia Trade On?
PharmaEssentia is listed and trades on the Taiwan stock exchange.
Is PharmaEssentia a Good Stock to Buy?
Determining whether PharmaEssentia—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6446 quote. (ISIN: TW0006446008)
What Is the PharmaEssentia Stock Price Today?
The PharmaEssentia stock price today is 1,195.00.
What Is the Stock Symbol for PharmaEssentia?
The stock symbol for PharmaEssentia is "6446."
What Stock Exchange Does PharmaEssentia Trade On?
PharmaEssentia is listed and trades on the Taiwan stock exchange.
Is PharmaEssentia a Good Stock to Buy?
Determining whether PharmaEssentia—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6446 quote. (ISIN: TW0006446008)
1,195.00
+35.00(+3.02%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,145.00
1,215.00
52 wk Range
452.50
1,215.00
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,145.001,215.00
52 wk Range
452.501,215.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.14%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.14%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6446 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
906.33
Downside
-24.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- PharmaEssentia acquires Canadian partner FORUS for $36.5 million
- Investing.com
Pro
- PharmaEssentia acquires Canadian partner FORUS for $36.5 million
- Investing.com
Pro
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 906.33
(-24.16% Downside)
Earnings
Latest Release
May 13, 2026
EPS / Forecast
5.79 / 4.38
Revenue / Forecast
5.12B / 5.05B
Compare 6446 to Peers and Sector
Metrics to compare | 6446 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6446PeersSector | |
|---|---|---|---|---|
P/E Ratio | 72.7x | 0.0x | −0.4x | |
PEG Ratio | 1.40 | 0.00 | 0.00 | |
Price/Book | 12.5x | 0.0x | 2.6x | |
Price / LTM Sales | 24.6x | 0.0x | 3.0x | |
Upside (Analyst Target) | −16.4% | 0.0% | 56.2% | |
Fair Value Upside | Unlock | 0.0% | 8.9% | Unlock |
PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the PharmaEssentia (6446) Stock Price Today?
The PharmaEssentia stock price today is 1,195.00 TWD.
What Stock Exchange Does PharmaEssentia Trade On?
PharmaEssentia is listed and trades on the Taiwan Stock Exchange.
What Is the Stock Symbol for PharmaEssentia?
The stock symbol for PharmaEssentia is "6446."
Does PharmaEssentia Pay Dividends? What’s The Current Dividend Yield?
The PharmaEssentia dividend yield is 0.14%.
What Is the PharmaEssentia Market Cap?
As of today, PharmaEssentia market cap is 431.09B TWD.
What Is PharmaEssentia's Earnings Per Share (TTM)?
The PharmaEssentia EPS (TTM) is 15.96.
When Is the Next PharmaEssentia Earnings Date?
PharmaEssentia will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is 6446 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has PharmaEssentia Stock Split?
PharmaEssentia has split 4 times.
How Many Employees Does PharmaEssentia Have?
PharmaEssentia has 131 employees.
What is the current trading status of PharmaEssentia (6446)?
As of Jun 26, 2026, PharmaEssentia (6446) is trading at a price of 1,195.00 TWD, with a previous close of 565.00 TWD. The stock has fluctuated within a day range of 1,145.00 TWD to 1,215.00 TWD, while its 52-week range spans from 452.50 TWD to 1,215.00 TWD.
What Is PharmaEssentia (6446) Price Target According to Analysts?
The average 12-month price target for PharmaEssentia is 906.33 TWD, with a high estimate of 1138 TWD and a low estimate of 555 TWD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -24.16% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.